BioMarin Pharmaceutical - 20 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits. The latest closing stock price for BioMarin Pharmaceutical as of August 16, 2019 is 76.50.
  • The all-time high BioMarin Pharmaceutical stock price is 149.13, which is 94.9% above the current share price.
  • The BioMarin Pharmaceutical 52-week high stock price is 106.07, which is 38.7% above the current share price.
  • The BioMarin Pharmaceutical 52-week low stock price is 71.71, which is 6.3% below the current share price.
  • The average BioMarin Pharmaceutical stock price for the last 52 weeks is 90.40.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 87.0817 84.9600 98.6200 71.7100 76.5000 -10.16%
2018 92.1163 91.0300 106.0700 76.0100 85.1500 -4.51%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4456 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.729B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.351B 13.94
Gilead Sciences (GILD) United States $79.964B 9.82
Celgene (CELG) United States $67.146B 10.39
Vertex Pharmaceuticals (VRTX) United States $47.536B 51.37
Biogen (BIIB) United States $42.733B 7.59
Illumina (ILMN) United States $42.067B 49.42
CSL (CSLLY) Australia $35.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.603B 14.80
Alexion Pharmaceuticals (ALXN) United States $24.856B 13.10
Incyte (INCY) United States $17.876B 52.61
Exact Sciences (EXAS) United States $15.515B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
Seattle Genetics (SGEN) United States $12.808B 0.00
Genmab (GNMSF) Denmark $12.376B 62.91
Guardant Health (GH) United States $9.438B 0.00
Sarepta Therapeutics (SRPT) United States $9.289B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.973B 0.00
Galapagos (GLPG) Belgium $8.822B 0.00
QIAGEN (QGEN) Netherlands $7.800B 25.62
Bio-Techne Corp (TECH) United States $7.483B 51.72
BeiGene (BGNE) Cayman Islands $6.826B 0.00
Bluebird Bio (BLUE) United States $6.633B 0.00
Exelixis (EXEL) United States $6.579B 17.10
Amarin (AMRN) Ireland $5.412B 0.00
Horizon Pharma Public (HZNP) Ireland $5.034B 12.80
Ascendis Pharma (ASND) Denmark $4.822B 0.00
Repligen (RGEN) United States $4.774B 92.64
ARGENX SE-ADR (ARGX) Netherlands $4.379B 0.00
Moderna (MRNA) United States $4.345B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.278B 0.00
Blueprint Medicines (BPMC) United States $4.129B 0.00
China Biologic Products (CBPO) China $3.889B 24.27
Spark Therapeutics (ONCE) United States $3.871B 0.00
MorphoSys AG (MOR) Germany $3.793B 0.00
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Alkermes (ALKS) Ireland $3.402B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.384B 0.00
Immunomedics (IMMU) United States $2.868B 0.00
Genomic Health (GHDX) United States $2.783B 52.20
Arena Pharmaceuticals (ARNA) United States $2.776B 5.97
Amicus Therapeutics (FOLD) United States $2.640B 0.00
NeoGenomics (NEO) United States $2.621B 140.22
CRISPR Therapeutics AG (CRSP) Switzerland $2.599B 0.00
Medicines (MDCO) United States $2.596B 0.00
MyoKardia (MYOK) United States $2.487B 0.00
Acceleron Pharma (XLRN) United States $2.424B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Reata Pharmaceuticals (RETA) United States $2.280B 0.00
Emergent Biosolutions (EBS) United States $2.252B 33.84
UniQure (QURE) Netherlands $2.154B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.093B 0.00
Cambrex (CBM) United States $2.016B 25.49
Akcea Therapeutics (AKCA) United States $1.980B 0.00
Zai Lab (ZLAB) China $1.960B 0.00
Myriad Genetics (MYGN) United States $1.873B 19.65
Ligand Pharmaceuticals (LGND) United States $1.805B 22.82
Denali Therapeutics (DNLI) United States $1.740B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.673B 0.00
Insmed (INSM) United States $1.481B 0.00
RA PHARMCTL INC (RARX) United States $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
AnaptysBio (ANAB) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.317B 0.00
Sangamo Therapeutics (SGMO) United States $1.313B 0.00
Editas Medicine (EDIT) United States $1.270B 0.00
Epizyme (EPZM) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.214B 0.00
Athenex (ATNX) United States $1.190B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.186B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.182B 0.00
Innoviva (INVA) United States $1.162B 3.36
Zymeworks (ZYME) Canada $1.034B 0.00
Alector (ALEC) United States $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.982B 0.00
Twist Bioscience (TWST) United States $0.965B 0.00
Cara Therapeutics (CARA) United States $0.928B 0.00
Principia Biopharma (PRNB) United States $0.892B 465.13
Adverum Biotechnologies (ADVM) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.845B 0.00
ANI Pharmaceuticals (ANIP) United States $0.829B 13.85
ZIOPHARM Oncology Inc (ZIOP) United States $0.823B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.809B 29.21
Arvinas (ARVN) United States $0.806B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.802B 0.00
Codexis (CDXS) United States $0.781B 0.00
Cytokineticsorporated (CYTK) United States $0.778B 0.00
Anika Therapeutics (ANIK) United States $0.775B 27.42
Retrophin (RTRX) United States $0.765B 0.00
WAVE Life Sciences (WVE) Singapore $0.732B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
Vericel (VCEL) United States $0.720B 0.00
Stemline Therapeutics (STML) United States $0.670B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.666B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Zealand Pharma (ZEAL) Denmark $0.651B 7.55
Heska (HSKA) United States $0.569B 73.68
MiMedx (MDXG) United States $0.559B 0.00
DBV Technologies S.A (DBVT) France $0.542B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Cellectis S.A (CLLS) France $0.511B 0.00
Intra-Cellular Therapies (ITCI) United States $0.502B 0.00
Revance Therapeutics (RVNC) United States $0.500B 0.00
Precision BioSciences (DTIL) United States $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
CytomX Therapeutics (CTMX) United States $0.424B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Agenus (AGEN) United States $0.389B 0.00
PHARMA MAR SA (PHMMF) Spain $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
AC Immune SA (ACIU) Switzerland $0.363B 26.90
Gritstone Oncology (GRTS) United States $0.350B 0.00
Arcus Biosciences (RCUS) United States $0.338B 0.00
Bellus Health (BLUSF) Canada $0.325B 0.00
Kadmon Holdings (KDMN) United States $0.324B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Scholar Rock Holding (SRRK) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.312B 0.00
Prothena (PRTA) Ireland $0.309B 0.00
Clovis Oncology (CLVS) United States $0.306B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Sorrento Therapeutics (SRNE) United States $0.293B 0.00
PDL BioPharma (PDLI) United States $0.292B 7.53
Kindred Biosciences (KIN) United States $0.284B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.269B 0.00
Geron (GERN) United States $0.266B 0.00
Dynavax Technologies (DVAX) United States $0.260B 0.00
Cellular Biomedicine (CBMG) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.249B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.247B 0.00
ChromaDex (CDXC) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Kamada (KMDA) Israel $0.214B 8.17
Five Prime Therapeutics (FPRX) United States $0.214B 0.00
PHASEBIO PHARMA (PHAS) United States $0.212B 0.00
Prometic Life Sciences (PFSCF) Canada $0.210B 0.00
Seres Therapeutics (MCRB) United States $0.208B 0.00
MannKind (MNKD) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Compugen (CGEN) Israel $0.194B 0.00
Spero Therapeutics (SPRO) United States $0.189B 0.00
Novavax (NVAX) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.180B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Cerecor (CERC) United States $0.151B 0.00
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Synlogic (SYBX) United States $0.146B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 5.62
Acorda Therapeutics (ACOR) United States $0.130B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.123B 0.00
Celyad SA (CYAD) Belgium $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.113B 0.00
Liquidia Technologies (LQDA) United States $0.112B 0.00
Aduro Biotech (ADRO) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
TOCAGEN INC (TOCA) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Verastem (VSTM) United States $0.095B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Catalyst Biosciences (CBIO) United States $0.083B 0.00
Menlo Therapeutics (MNLO) United States $0.082B 0.00
Trevena (TRVN) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
VBI Vaccines (VBIV) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Antibe Therapeutics (ATBPF) Canada $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 30.80
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.029B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.07
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00